• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺结核患者病灶中细菌群落与药物敏感性的关联。

Association of bacteriomes with drug susceptibility in lesions of pulmonary tuberculosis patients.

作者信息

Du Weili, Zhao Yingli, Zhang Chen, Zhang Li, Zhou Lijuan, Sun Zuyu, Huang Xiaojie, Zhang Nana, Liu Zichen, Li Kun, Che Nanying

机构信息

Department of Pathology, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beiguandajie 9#, Tongzhou Dist, Beijing, 101149, China.

出版信息

Heliyon. 2024 Sep 6;10(18):e37583. doi: 10.1016/j.heliyon.2024.e37583. eCollection 2024 Sep 30.

DOI:10.1016/j.heliyon.2024.e37583
PMID:39309911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11414563/
Abstract

Understanding how the bacteriomes in tuberculous lesions can be influenced by the susceptibility of (MTB) can provide valuable information for preventing and treating drug resistant tuberculosis (DR-TB). High-throughput 16S rRNA sequencing was employed to analyze the bacteriome in pulmonary TB lesions from 14 patients with DR-TB and 47 patients with drug sensitive tuberculosis (DS-TB), along with 18 normal lung tissues (NT) from 18 lung cancer patients serving as the bacterial baseline. The phylogenetic investigation of communities by reconstruction of unobserved states2 (PICRUSt2) algorithm was utilized to predict bacterial metabolic functions. The major phyla of pulmonary bacteriomes included , , , and . Alpha diversity indices, including ACE, Chao1, Shannon and OTU observed, all demonstrated different bacterial communities of DS-TB samples from that of NT samples; while only Shannon indicated difference between DR-TB and NT samples. The analysis of similarity (ANOSIM) showed significantly different bacterial communities within TB lesions compared to NT samples (R = 0.418, p = 0.001). However, difference was not observed between DR-TB and DS-TB samples (ANOSIM, R = 0.069, p = 0.173). The bacterial profiles within each DR-TB individual appeared unique, with no obvious clusters corresponding to drug-resistant phenotypes. Nevertheless, indicator genera identified in DR-TB and DS-TB lesions demonstrated distinctive micro-ecological environments. Most COG functions were enriched in TB lesions, and the most significant one was [J] translation, ribosomal structure and biogenesis. The distinct enrichment patterns of bacterial enzymes in DR-TB and DS-TB lesions suggest that pulmonary bacterial activities can be modulated by the susceptibility of MTB bacilli. This study provides fresh perspectives and strategies for the precise diagnosis and assessment of drug resistance tuberculosis.

摘要

了解结核病变中的细菌群落如何受到结核分枝杆菌(MTB)易感性的影响,可为预防和治疗耐多药结核病(DR-TB)提供有价值的信息。采用高通量16S rRNA测序分析了14例DR-TB患者和47例药物敏感结核病(DS-TB)患者的肺结核病变中的细菌群落,以及18例肺癌患者的18个正常肺组织(NT)作为细菌基线。利用未观察状态2(PICRUSt2)算法的群落系统发育调查来预测细菌代谢功能。肺部细菌群落的主要门类包括、、、和。包括ACE、Chao1、Shannon和观察到的OTU在内的α多样性指数均显示DS-TB样本与NT样本的细菌群落不同;而只有Shannon指数表明DR-TB样本与NT样本之间存在差异。相似性分析(ANOSIM)显示,与NT样本相比,结核病变内的细菌群落有显著差异(R = 0.418,p = 0.001)。然而,DR-TB和DS-TB样本之间未观察到差异(ANOSIM,R = 0.069,p = 0.173)。每个DR-TB个体内的细菌谱似乎都是独特的,没有明显的簇与耐药表型相对应。然而,在DR-TB和DS-TB病变中鉴定出的指示菌属显示出独特的微生态环境。大多数COG功能在结核病变中富集,最显著的是[J]翻译、核糖体结构和生物发生。DR-TB和DS-TB病变中细菌酶的不同富集模式表明,肺部细菌活动可受MTB杆菌易感性的调节。本研究为耐多药结核病的精确诊断和评估提供了新的视角和策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebe/11414563/b056f545f069/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebe/11414563/e2766f60d869/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebe/11414563/4329e385d5de/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebe/11414563/8799f829666e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebe/11414563/b056f545f069/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebe/11414563/e2766f60d869/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebe/11414563/4329e385d5de/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebe/11414563/8799f829666e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebe/11414563/b056f545f069/gr4.jpg

相似文献

1
Association of bacteriomes with drug susceptibility in lesions of pulmonary tuberculosis patients.肺结核患者病灶中细菌群落与药物敏感性的关联。
Heliyon. 2024 Sep 6;10(18):e37583. doi: 10.1016/j.heliyon.2024.e37583. eCollection 2024 Sep 30.
2
Bacteriomes in lesions of pulmonary tuberculosis and its association with status of Mycobacterium tuberculosis excretion.肺结核病变中的细菌组与结核分枝杆菌排出状况的关系。
BMC Microbiol. 2022 Nov 23;22(1):280. doi: 10.1186/s12866-022-02698-5.
3
Spatial bacterial subpopulations of a human lung lobe and their potential impact on the progression of pulmonary tuberculosis.人类肺叶中细菌亚群的空间分布及其对肺结核进展的潜在影响。
Microb Pathog. 2022 Aug;169:105656. doi: 10.1016/j.micpath.2022.105656. Epub 2022 Jun 28.
4
Alveolar microbiota profile in patients with human pulmonary tuberculosis and interstitial pneumonia.肺泡微生物组在人肺结核和间质性肺炎患者中的特征。
Microb Pathog. 2020 Feb;139:103851. doi: 10.1016/j.micpath.2019.103851. Epub 2019 Nov 9.
5
Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing.结核分枝杆菌 16S rRNA 焦磷酸测序揭示的痰液微生物组。
PLoS One. 2013;8(1):e54574. doi: 10.1371/journal.pone.0054574. Epub 2013 Jan 24.
6
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.贝达喹啉-pretomanid-莫西沙星-吡嗪酰胺治疗敏感和耐药肺结核:一项 2c 期、开放标签、多中心、部分随机对照试验。
Lancet Infect Dis. 2024 Sep;24(9):1003-1014. doi: 10.1016/S1473-3099(24)00223-8. Epub 2024 May 17.
7
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
8
Characterization of Differentially Detectable Mycobacterium tuberculosis in the Sputum of Subjects with Drug-Sensitive or Drug-Resistant Tuberculosis before and after Two Months of Therapy.在接受两个月治疗前后,药物敏感或耐药结核病患者痰液中可检测到的结核分枝杆菌的特征。
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0060821. doi: 10.1128/AAC.00608-21.
9
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
10
Dynamic changes of respiratory microbiota associated with treatment outcome in drug-sensitive and drug-resistant pulmonary tuberculosis.与药物敏感和耐药性肺结核治疗效果相关的呼吸微生物群的动态变化。
Ann Clin Microbiol Antimicrob. 2024 Sep 9;23(1):83. doi: 10.1186/s12941-024-00742-y.

本文引用的文献

1
Identification of Resistance to Common Antibiotics: An Overview of Current Methods and Techniques.常见抗生素耐药性的鉴定:当前方法与技术概述
Infect Drug Resist. 2024 Apr 12;17:1491-1506. doi: 10.2147/IDR.S457308. eCollection 2024.
2
Machine learning analysis of SERS fingerprinting for the rapid determination of infection and drug resistance.用于快速测定感染和耐药性的表面增强拉曼光谱指纹图谱的机器学习分析
Comput Struct Biotechnol J. 2022 Sep 26;20:5364-5377. doi: 10.1016/j.csbj.2022.09.031. eCollection 2022.
3
The Relevance of Host Gut Microbiome Signature Alterations on de novo Fatty Acids Synthesis in Patients with Multi-Drug Resistant Tuberculosis.
宿主肠道微生物群特征改变对耐多药结核病患者从头脂肪酸合成的相关性
Infect Drug Resist. 2022 Sep 21;15:5589-5600. doi: 10.2147/IDR.S372122. eCollection 2022.
4
The gut microbiota mediates protective immunity against tuberculosis modulation of lncRNA.肠道微生物群介导抗结核保护性免疫 - lncRNA 的调节。
Gut Microbes. 2022 Jan-Dec;14(1):2029997. doi: 10.1080/19490976.2022.2029997.
5
16S rRNA Methyltransferases as Novel Drug Targets Against Tuberculosis.16S rRNA 甲基转移酶作为抗结核药物的新靶点。
Protein J. 2022 Feb;41(1):97-130. doi: 10.1007/s10930-021-10029-2. Epub 2022 Feb 3.
6
Rational Engineering of Homoserine O-Succinyltransferase from for Reduced Feedback Inhibition by Methionine.理性工程甲硫氨酸对同型丝氨酸-O-琥珀酰转移酶的反馈抑制。
J Agric Food Chem. 2022 Feb 9;70(5):1571-1578. doi: 10.1021/acs.jafc.1c07211. Epub 2022 Jan 27.
7
Microbiome in sputum as a potential biomarker of chronicity in pulmonary resistant to rifampicin-tuberculosis and multidrug-resistant-tuberculosis patients.痰微生物组作为耐利福平-肺结核和耐多药-肺结核患者慢性的潜在生物标志物。
Int J Mycobacteriol. 2021 Jul-Sep;10(3):260-267. doi: 10.4103/ijmy.ijmy_132_21.
8
Altered Microbial Composition of Drug-Sensitive and Drug-Resistant TB Patients Compared with Healthy Volunteers.与健康志愿者相比,药物敏感型和耐药型肺结核患者的微生物组成变化
Microorganisms. 2021 Aug 18;9(8):1762. doi: 10.3390/microorganisms9081762.
9
Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis.富含厌氧菌的肠道微生物群可预测肺结核的促炎反应。
EBioMedicine. 2021 May;67:103374. doi: 10.1016/j.ebiom.2021.103374. Epub 2021 May 8.
10
Whole lung tissue is the preferred sampling method for amplicon-based characterization of murine lung microbiota.全肺组织是基于扩增子的鼠肺微生物组特征分析的首选采样方法。
Microbiome. 2021 May 5;9(1):99. doi: 10.1186/s40168-021-01055-4.